Angiex
PrivateLast Round
VC Round
Nov 17, 2025
Total Funding Raised
$48.5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Angiex is a biopharmaceutical company that develops vascular-targeted biotherapeutics and nuclear-delivered antibody-drug conjugates for the treatment of solid cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Angiex Comparables
Compare Angiex with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adcendo | 87% | |
| Adcytherix | 81% | |
| Adcentrx Therapeutics | 81% |
Angiex Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Nov 17, 2025 | ||||
| Series B | Aug 18, 2021 | ||||
| Seed | Jul 27, 2017 | ||||
| Grant | Nov 2, 2016 |
Key People
Founding team and executive leadership
Angiex Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Paulson Investment Company | VC Round |
| Presight Capital | Series B |
| Starling Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 296% MoM, from 652 to 2.6K.
- Apr 17, 2026
Presented in vivo data for AGX101, a cancer therapy candidate.
Recent news
Latest coverage and updates
- is_developingAug 27, 2026
Angiex is developing AGX101.
Angiex Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Angiex's valuation, stock price, and market status.
Is Angiex a public or private company?
Angiex is a private company.
What is the current stock price of Angiex?
Angiex is a private company with no public stock price. No recent secondary market data is available.
How much is Angiex worth (valuation)?
Valuation information for Angiex is not publicly available.
Can I buy Angiex stock?
Angiex shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Angiex's last funding round?
Angiex's most recent funding round was Series B on August 18, 2021.
Who are the main investors in Angiex?
Key investors in Angiex include Presight Capital.
Will Angiex IPO soon?
No public IPO plans have been announced for Angiex.
How can I track Angiex secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Angiex's secondary market activity and sign up for updates.